Wasatch Advisors’s Exact Sciences EXAS Stock Holding History

Wasatch Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-239,208	Closed	-$13.1M	–	231
2025 Q3	$13.1M	Sell	239,208 -178,939	-43%	-$8.94M	0.07%	144
2025 Q2	$22.2M	Sell	418,147 -77,975	-16%	-$3.96M	0.12%	126
2025 Q1	$21.5M	Buy	496,122 +78,195	+19%	+$3.96M	0.12%	124
2024 Q4	$23.5M	Sell	417,927 -19,946	-5%	-$1.24M	0.12%	129
2024 Q3	$29.8M	Sell	437,873 -69,314	-14%	-$3.91M	0.15%	117
2024 Q2	$21.4M	Buy	507,187 +207,939	+69%	+$11.4M	0.11%	124
2024 Q1	$20.7M	Buy	299,248 +37,668	+14%	+$2.38M	0.11%	134
2023 Q4	$19.4M	Sell	261,580 -13,248	-5%	-$868K	0.11%	130
2023 Q3	$18.7M	Sell	274,828 -48,954	-15%	-$4.15M	0.12%	123
2023 Q2	$30.4M	Sell	323,782 -26,726	-8%	-$2.08M	0.18%	99
2023 Q1	$23.8M	Sell	350,508 -106,120	-23%	-$6.82M	0.15%	122
2022 Q4	$22.6M	Sell	456,628 -170,746	-27%	-$6.98M	0.15%	126
2022 Q3	$20.4M	Buy	627,374 +161,734	+35%	+$6.67M	0.14%	134
2022 Q2	$18.3M	Buy	465,640 +159,064	+52%	+$8.51M	0.12%	141
2022 Q1	$21.4M	Sell	306,576 -4,643	-1%	-$339K	0.11%	151
2021 Q4	$24.2M	Sell	311,219 -514	-0.2%	-$45.4K	0.1%	161
2021 Q3	$29.8M	Buy	311,733 +2,387	+0.8%	+$252K	0.12%	144
2021 Q2	$38.5M	Buy	309,346 +59,508	+24%	+$7.1M	0.16%	128
2021 Q1	$32.9M	Sell	249,838 -129,146	-34%	-$17.7M	0.15%	123
2020 Q4	$50.2M	Sell	378,984 -315	-0.1%	-$38.1K	0.25%	96
2020 Q3	$38.7M	Buy	379,299 +120,531	+47%	+$10.4M	0.25%	99
2020 Q2	$22.5M	Sell	258,768 -27,321	-10%	-$2.18M	0.16%	118
2020 Q1	$16.6M	Sell	286,089 -432,605	-60%	-$35.1M	0.17%	103
2019 Q4	$66.5M	Buy	718,694 +2,866	+0.4%	+$252K	0.55%	61
2019 Q3	$64.7M	Sell	715,828 -4,075	-0.6%	-$464K	0.62%	58
2019 Q2	$85M	Sell	719,903 -96,957	-12%	-$9.77M	0.83%	48
2019 Q1	$70.8M	Sell	816,860 -138,001	-14%	-$11.7M	0.77%	51
2018 Q4	$60.3M	Buy	954,861 +2,142	+0.2%	+$147K	0.8%	49
2018 Q3	$75.2M	Sell	952,719 -146,347	-13%	-$9.54M	0.86%	44
2018 Q2	$65.7M	Sell	1,099,066 -50,418	-4%	-$2.71M	0.79%	49
2018 Q1	$46.4M	Sell	1,149,484 -121,659	-10%	-$5.93M	0.6%	59
2017 Q4	$66.8M	Sell	1,271,143 -287,868	-18%	-$15.4M	0.89%	43
2017 Q3	$73.5M	Sell	1,559,011 -427,908	-22%	-$17.2M	1%	37
2017 Q2	$70.3M	Sell	1,986,919 -221,138	-10%	-$6.83M	0.98%	36
2017 Q1	$52.2M	Buy	2,208,057 +521,478	+31%	+$10.3M	0.77%	48
2016 Q4	$22.5M	Sell	1,686,579 -35,848	-2%	-$579K	0.34%	72
2016 Q3	$32M	Sell	1,722,427 -1,937,747	-53%	-$34.1M	0.48%	62
2016 Q2	$44.8M	Buy	3,660,174 +64,674	+2%	+$487K	0.69%	43
2016 Q1	$23.3M	Buy	3,595,500 +1,860,248	+107%	+$11.9M	0.36%	78
2015 Q4	$16M	Buy	1,735,252 +797,375	+85%	+$7.41M	0.22%	119
2015 Q3	$16.9M	Sell	937,877 -27,435	-3%	-$630K	0.23%	128
2015 Q2	$28.7M	Sell	965,312 -11,734	-1%	-$295K	0.31%	107
2015 Q1	$21.5M	Sell	977,046 -755,394	-44%	-$19.2M	0.22%	124
2014 Q4	$47.5M	Sell	1,732,440 -1,065,753	-38%	-$25.9M	0.49%	73
2014 Q3	$54.2M	Sell	2,798,193 -161,875	-5%	-$2.97M	0.57%	55
2014 Q2	$50.4M	Sell	2,960,068 -9,480	-0.3%	-$131K	0.49%	68
2014 Q1	$42.1M	Sell	2,969,548 -896,392	-23%	-$12.1M	0.41%	85
2013 Q4	$45.2M	Buy	3,865,940 +227,217	+6%	+$2.61M	0.44%	79
2013 Q3	$43M	Sell	3,638,723 -149,922	-4%	-$1.92M	0.45%	81
2013 Q2	$52.7M	Buy	+3,788,645	New	+$41.2M	0.58%	49

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wasatch Advisors's EXAS Position: Q4 2025 in Review

Wasatch Advisors sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 239,208 shares — an estimated $13.1M sold.

Wasatch Advisors first reported a position in EXAS in Q2 2013 and held it in 50 quarters. The position peaked at $85M in Q2 2019. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

Wasatch Advisors reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
Wasatch Advisors sold 239,208 Exact Sciences shares in Q4 2025, an estimated $13.1M.
Wasatch Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 50 quarters.
Wasatch Advisors's Exact Sciences position peaked at $85M in Q2 2019.
711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Wasatch Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.